| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
HCA Healthcare, Inc.$394.37
-2.38 (-0.6%)
F 16Pipeline Score Tools & Services · Clinical
Market Cap
110.77 B
EPS
28.71
P/E Ratio
17.46 $
Value Trade
803.77 M
SEC Financials
Q1 2026Dilution Risk
Revenue
19.11 B
Operating CF
2.01 B
Total Assets
61.45 B
Total Liabilities
61.45 B
Equity
-6.30 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
940.00 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Apr 29, 2026
Overview
Volume
349.10 K
52 Week Range
314.43 - 556.52
% held by Insiders
32.46 %
% held by Institutions
61.7 %
Enterprise Value
161.58 B
Total Shares
221.95 M
Short %
2.89 %
Float Shares
180.22 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
F16
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 13%
Large Pharma (rank 788 of 905)
Percentile RankHCA Healthcare, Inc. has significant pipeline risk (16/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in HCA
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
HCA Healthcare, Inc. (HCA) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
HCA
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HCA
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HCA
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HCA Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
HCA Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-12-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-12-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-12-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-HCA
May 27, 2026HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
HCA Healthcare has announced an agreement to acquire The College of Health Care Professions. This acquisition aims to enhance HCA's educational offerings and workforce development. Further details regarding the transaction and its implications for both organizations have not been disclosed.
Read more →-HCA
May 19, 2026HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
HCA Healthcare colleagues participated in an annual Days of Service initiative, contributing over 41,800 hours of volunteer work. This effort highlights the company's commitment to community service and employee engagement. The initiative not only benefits local communities but also strengthens teamwork among employees.
Read more →-HCA
Apr 30, 2026HCA Healthcare, Inc. to Present at May Conference
HCA Healthcare, Inc. is scheduled to present at the RBC Global Healthcare Conference on May 20, 2026, at 11:30am ET. The presentation will be accessible via a live audio webcast, with materials available on the company's Investor Relations website. HCA Healthcare operates 189 hospitals and approximately 2,600 ambulatory care sites across 19 states and the UK.
Read more →-HCA
Apr 27, 2026HCA Announces Proposed Public Offering of Senior Notes
HCA Healthcare, Inc. has announced a proposed public offering of senior notes through its subsidiary, HCA Inc. The actual terms of the offering will depend on market conditions at the time of pricing. The proceeds from this offering are intended for general corporate purposes, which may include repaying outstanding borrowings.
Read more →-HCA
Apr 27, 2026HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs
HCA Healthcare has appointed Cynthia Cifuentes-Finkel as the new Senior Vice President of Marketing and Corporate Affairs. This strategic move is aimed at enhancing the company's marketing efforts and corporate communications. Cifuentes-Finkel's extensive experience is expected to contribute positively to HCA's initiatives.
Read more →-HCA
Apr 24, 2026HCA Healthcare Reports First Quarter 2026 Results
HCA Healthcare reported its first quarter 2026 results, showing a revenue increase of 4.3% to $19.109 billion and a net income rise of 0.6% to $1.620 billion. Despite challenges such as a 42% drop in respiratory-related admissions and adverse weather impacts, the company experienced significant cash flow growth. The board declared a quarterly cash dividend of $0.78 per share, reinforcing its commitment to shareholders.
Read more →-HCA
Apr 16, 202629 HCA Healthcare Hospitals Recognized on Modern Healthcare’s 100 Top Hospitals Powered by Premier
HCA Healthcare has achieved a significant milestone with 29 of its hospitals being recognized on Modern Healthcare's 100 Top Hospitals list, powered by Premier. This accolade underscores the commitment of HCA to provide high-quality healthcare services. The recognition is expected to bolster the reputation of these hospitals in the healthcare community.
Read more →Competitive Position
How HCA ranks across every disease it competes inCompetitive Position is a premium feature
See how HCA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial